Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Journal articles
  4. Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread
 
research article

Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread

Hangartner, L.
•
Zellweger, R. M.
•
Giobbi, M.
Show more
2006
Journal of Experimental Medicine

The biological relevance of nonneutralizing antibodies elicited early after infection with noncytopathic persistence-prone viruses is unclear. We demonstrate that cytotoxic T lymphocyte-deficient TgH(KL25) mice, which are transgenic for the heavy chain of the lymphocytic choriomeningitis virus (LCMV)-neutralizing monoclonal antibody KL25, mount a focused neutralizing antibody response following LCMV infection, and that this results in the emergence of neutralization escape virus variants. Further investigation revealed that some of the escape variants that arose early after infection could still bind to the selecting antibody. In contrast, no antibody binding could be detected for late isolates, indicating that binding, but nonneutralizing, antibodies exerted a selective pressure on the virus. Infection of naive TgH(KL25) mice with distinct escape viruses differing in their antibody-binding properties revealed that nonneutralizing antibodies accelerated clearance of antibody-binding virus variants in a partly complement-dependent manner. Virus variants that did not bind antibodies were not affected. We therefore conclude that nonneutralizing antibodies binding to the same antigenic site as neutralizing antibodies are biologically relevant by limiting early viral spread.

  • Files
  • Details
  • Metrics
Type
research article
DOI
10.1084/jem.20051557
Author(s)
Hangartner, L.
Zellweger, R. M.
Giobbi, M.
Weber, J.
Eschli, B.
McCoy, K. D.
Harris, N.  
Recher, M.
Zinkernagel, R. M.
Hengartner, H.
Date Issued

2006

Published in
Journal of Experimental Medicine
Volume

203

Issue

8

Start page

2033

End page

42

Subjects

Animals

•

Antibodies, Viral/*immunology

•

Antigens, Viral/chemistry/immunology

•

B-Lymphocytes/immunology

•

Binding Sites, Antibody/*immunology

•

Complement Activation/immunology

•

Glycoproteins/chemistry/immunology

•

Lymphocytic Choriomeningitis/*virology

•

Lymphocytic choriomeningitis

•

virus/chemistry/genetics/*immunology/*physiology

•

Membrane Glycoproteins/*metabolism

•

Mice

•

Mice, Inbred C57BL

•

Neutralization Tests

•

Recombinant Proteins/immunology

•

T-Lymphocytes, Cytotoxic/immunology

•

Viral Proteins/chemistry/*immunology

Note

Hangartner, Lars Zellweger, Raphael M Giobbi, Mattia Weber, Jacqueline Eschli, Bruno McCoy, Kathy D Harris, Nicola Recher, Mike Zinkernagel, Rolf M Hengartner, Hans Research Support, Non-U.S. Gov't United States The Journal of experimental medicine J Exp Med. 2006 Aug 7;203(8):2033-42. Epub 2006 Jul 31.

Editorial or Peer reviewed

REVIEWED

Written at

OTHER

EPFL units
UPHARRIS  
Available on Infoscience
January 6, 2010
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/45074
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés